Ontario announces $741 million diabetes strategy Nevanac: new ophthalmic NSAID coming soon Forteo approved for severe steroid-induced osteoporosis Codeine too risky for breastfed infants Coming soon: new IV cephalosporin active against MRSA CVS Caremark to acquire Longs Drug Stores Low vitamin D levels associated with increased mortality “Non-dairy” acidophilus products: milk allergy warning Uncertainty regarding ezetimibe and cancer risk Practice Issues: Adverse Reactions - ESAs for cancer-related anemia Trials assess ESA use for the treatment of anemia among patients with cancer. First Previous 4054 4055 4056 4057 4058 Next Last
